Corcept Therapeutics Inc financial data

Symbol
CORT on Nasdaq
Location
101 Redwood Shores Parkway, Redwood City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315 % -32.1%
Quick Ratio 8.56 % +17.1%
Debt-to-equity 25.9 % +21.9%
Return On Equity 16.1 % -34.9%
Return On Assets 12.8 % -37.3%
Operating Margin 8.85 % -61.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +0.39%
Common Stock, Shares, Outstanding 105M shares +1.65%
Entity Public Float 2.69B USD +47.3%
Common Stock, Value, Issued 139K USD +2.96%
Weighted Average Number of Shares Outstanding, Basic 104M shares +0.17%
Weighted Average Number of Shares Outstanding, Diluted 119M shares +5.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 741M USD +17.9%
Research and Development Expense 260M USD +12.6%
Costs and Expenses 676M USD +39.2%
Operating Income (Loss) 65.6M USD -54.3%
Nonoperating Income (Expense) 22.9M USD -0.17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 88.5M USD -46.8%
Income Tax Expense (Benefit) -17.6M USD -172%
Net Income (Loss) Attributable to Parent 106M USD -25.2%
Earnings Per Share, Basic 1 USD/shares -25.9%
Earnings Per Share, Diluted 0 USD/shares -30.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 125M USD -8.85%
Marketable Securities, Current 297M USD +22%
Accounts Receivable, after Allowance for Credit Loss, Current 69.6M USD +16.6%
Inventory, Net 12.3M USD +53.4%
Other Assets, Current 6M USD +31%
Assets, Current 541M USD +15.9%
Deferred Income Tax Assets, Net 153M USD +20.7%
Property, Plant and Equipment, Net 2.09M USD -28.5%
Operating Lease, Right-of-Use Asset 4.78M USD -13.2%
Other Assets, Noncurrent 8.05M USD +15.4%
Assets 824M USD +5.02%
Accounts Payable, Current 34.4M USD +85.4%
Employee-related Liabilities, Current 25.5M USD +64.1%
Accrued Liabilities, Current 108M USD +36.5%
Liabilities, Current 172M USD +36.5%
Accrued Income Taxes, Noncurrent 14.1M USD +10%
Operating Lease, Liability, Noncurrent 5.31M USD -16.5%
Liabilities 192M USD +31.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.34M USD +49%
Retained Earnings (Accumulated Deficit) 619M USD +20.7%
Stockholders' Equity Attributable to Parent 632M USD -1.09%
Liabilities and Equity 824M USD +5.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 5.13M USD -78.4%
Net Cash Provided by (Used in) Financing Activities -39.8M USD -7230%
Net Cash Provided by (Used in) Investing Activities -3.17M USD +64.8%
Common Stock, Shares Authorized 280M shares 0%
Common Stock, Shares, Issued 138M shares +2.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -37.8M USD -367%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 125M USD -8.85%
Deferred Tax Assets, Valuation Allowance 17.5M USD +9.49%
Deferred Tax Assets, Gross 150M USD +38.6%
Operating Lease, Liability 6.36M USD -6.38%
Payments to Acquire Property, Plant, and Equipment 104K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 107M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid 7.73M USD -11.5%
Property, Plant and Equipment, Gross 4.48M USD +6.85%
Operating Lease, Liability, Current 1.05M USD +143%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.6M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.55M USD +12.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Income Tax Expense (Benefit) -13.7M USD -91.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.37M USD -29.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.65M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 3.47M USD -12%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 16.4M USD +26.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.7M USD +2.98%
Operating Lease, Payments 1M USD -49.4%
Additional Paid in Capital 832M USD +12.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 52K USD -56.3%
Depreciation, Depletion and Amortization 285K USD +138%
Deferred Tax Assets, Net of Valuation Allowance 131M USD +44.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%